Journals
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 1 of 1
2021-01-25 [p.446]
Q-292 — Ms. Rempel Garner (Calgary Nose Hill) — With regard to the Prime Minister's announcement in May 2020 of an agreement with CanSino Biologics Inc. (CanSinoBIO) in relation to the development of a potential COVID-19 vaccine: (a) what were the original details of the agreement, as understood by the government in May 2020; (b) on what date did the government first become aware that the agreement would not proceed as planned; (c) on what date did the government become aware that shipments of Ad5-nCoV were being blocked by the Chinese government; (d) what reason, if any, did the Chinese government provide to the government for blocking the shipment; (e) has the government transferred any money or any type of expenditures to CanSinoBIO since January 1, 2020, and, if so, what is the total amount sent, broken down by date of transfer; (f) what are the details of any contracts signed with CanSinoBIO since January 1, 2020, including the (i) amount, (ii) original value, (iii) final value, (iv) date the contract was signed, (v) description of goods or services, including volume; (g) was the National Security and Intelligence Advisor to the Prime Minister advised of the terms agreement prior to the Prime Minister's announcement, and, if so, did he approve of the agreement; (h) was the Department of National Defence or the Canadian Security Intelligence Service informed of the details of the agreement prior to the Prime Minister's announcement, and, if so, did they raise any concerns with the Office of the Prime Minister or the Privy Council Office; and (i) what were the results of any security analysis conducted in relation to CanSinoBIO? — Sessional Paper No. 8555-432-292.
Result: 1 - 1 of 1

Export As: XML CSV RSS

For more data options, please see Open Data